Difference between revisions of "Category:Mutation-specific medications"
Jump to navigation
Jump to search
m |
m |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
− | Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific mutations | + | Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific gene mutations. |
[[Category:Biomarker-specific medications]] | [[Category:Biomarker-specific medications]] |
Latest revision as of 17:07, 10 January 2020
Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific gene mutations.
Pages in category "Mutation-specific medications"
The following 69 pages are in this category, out of 69 total.